
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
Is the golden age of drug development over? Fat chance. Decade-by-decade comparisons show how new medicines improve on old ones. And that's innovation.
over 20 years ago
Time Machineover 20 years ago
States Curb Marketingover 20 years ago
From the Editor: Take Your Seatover 20 years ago
Viewpoint: In Your Wordsover 20 years ago
Quiz Answersover 20 years ago
Introduction: Pharm Exec at 25over 20 years ago
How Far We've Come





